1. Home
  2. KELYB vs SLDB Comparison

KELYB vs SLDB Comparison

Compare KELYB & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KELYB
  • SLDB
  • Stock Information
  • Founded
  • KELYB 1946
  • SLDB 2013
  • Country
  • KELYB United States
  • SLDB United States
  • Employees
  • KELYB N/A
  • SLDB N/A
  • Industry
  • KELYB Professional Services
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KELYB Consumer Discretionary
  • SLDB Health Care
  • Exchange
  • KELYB Nasdaq
  • SLDB Nasdaq
  • Market Cap
  • KELYB 483.4M
  • SLDB 433.0M
  • IPO Year
  • KELYB N/A
  • SLDB 2018
  • Fundamental
  • Price
  • KELYB $13.84
  • SLDB $5.39
  • Analyst Decision
  • KELYB
  • SLDB Strong Buy
  • Analyst Count
  • KELYB 0
  • SLDB 10
  • Target Price
  • KELYB N/A
  • SLDB $15.00
  • AVG Volume (30 Days)
  • KELYB 341.0
  • SLDB 788.7K
  • Earning Date
  • KELYB 11-06-2025
  • SLDB 11-05-2025
  • Dividend Yield
  • KELYB 2.17%
  • SLDB N/A
  • EPS Growth
  • KELYB N/A
  • SLDB N/A
  • EPS
  • KELYB N/A
  • SLDB N/A
  • Revenue
  • KELYB $4,495,900,000.00
  • SLDB N/A
  • Revenue This Year
  • KELYB $6.05
  • SLDB N/A
  • Revenue Next Year
  • KELYB $4.18
  • SLDB N/A
  • P/E Ratio
  • KELYB N/A
  • SLDB N/A
  • Revenue Growth
  • KELYB 0.97
  • SLDB N/A
  • 52 Week Low
  • KELYB $11.04
  • SLDB $2.41
  • 52 Week High
  • KELYB $21.22
  • SLDB $8.14
  • Technical
  • Relative Strength Index (RSI)
  • KELYB 52.45
  • SLDB 44.32
  • Support Level
  • KELYB $14.00
  • SLDB $4.87
  • Resistance Level
  • KELYB $15.05
  • SLDB $5.77
  • Average True Range (ATR)
  • KELYB 0.00
  • SLDB 0.30
  • MACD
  • KELYB -0.13
  • SLDB -0.03
  • Stochastic Oscillator
  • KELYB 12.87
  • SLDB 49.30

About KELYB Kelly Services Inc. Class B

Kelly Services Inc is a provider of workforce solutions and consulting, and staffing services. The company's operations are divided into four business segments, namely Professional & Industrial, Science, Education, Outsourcing & Consulting Group, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions, including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: